Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury

BACKGROUND: Intensive haemodialysis (IHD) in addition to bortezomib-based chemotherapy might be efficient to rapidly decrease serum immunoglobulin-free light chains removal in patients with multiple myeloma (MM) and to improve renal prognosis and survival. METHODS: The aim of this retrospective mult...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Kidney J
Glavni autori: Hudier, Laurent, Decaux, Olivier, Haddj-Elmrabet, Atmann, Lino, Marie, Mandart, Lise, Siohan, Pascale, Renaudineau, Eric, Sawadogo, Theophile, Lamy De La Chapelle, Thierry, Oger, Emmanuel, Bridoux, Frank, Vigneau, Cécile
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Onconephrology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887381/
https://ncbi.nlm.nih.gov/pubmed/29644064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx079
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items